The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Talamas-Rohana, P.
Right arrow Articles by Russell, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Talamas-Rohana, P.
Right arrow Articles by Russell, D. G.

The Journal of Immunology, Vol 144, Issue 12 4817-4824, Copyright © 1990 by American Association of Immunologists


ARTICLES

Lipophosphoglycan from Leishmania mexicana promastigotes binds to members of the CR3, p150,95 and LFA-1 family of leukocyte integrins

P Talamas-Rohana, SD Wright, MR Lennartz and DG Russell
Department of Pathology, NYU Medical Center, NY 10016.

The abundant surface glycolipid, promastigote lipophosphoglycan (LPG), of Leishmania promastigotes was isolated and reconstituted onto the surface of hydrophobic silica beads. These beads bound to both macrophages and monocytes, suggesting that phagocytes possess a receptor(s) capable of recognizing LPG. LPG beads were unable to bind to macrophages isolated from individuals with a genetic deficiency in the CD18 complex of leukocyte integrins (CR3, p150,95, and LFA-1), suggesting that one or more of these receptors were required for binding of LPG. Individual members of the CD18 complex were depleted from macrophages by plating cells on surfaces coated with anti-receptor mAb. These experiments indicated that CR3 and p150,95 from the CD18 complex, were the predominant mediators of attachment of LPG. The phagocyte receptor CR3 expresses two distinct binding sites, one that binds peptide ligands, such as C3bi, and a second site, that recognizes bacterial LPS. Antibody inhibition experiments and competition binding studies with synthetic peptides and soluble LPG indicated that LPG is recognized by the nonpeptide, or "LPS" binding site on CR3.


This article has been cited by other articles:


Home page
Infect. Immun.Home page
C. R. Carter, J. P. Whitcomb, J. A. Campbell, R. M. Mukbel, and M. A. McDowell
Complement Receptor 3 Deficiency Influences Lesion Progression during Leishmania major Infection in BALB/c Mice
Infect. Immun., December 1, 2009; 77(12): 5668 - 5675.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. Lippuner, D. Paape, A. Paterou, J. Brand, M. Richardson, A. J. Smith, K. Hoffmann, V. Brinkmann, C. Blackburn, and T. Aebischer
Real-time imaging of Leishmania mexicana-infected early phagosomes: a study using primary macrophages generated from green fluorescent protein-Rab5 transgenic mice
FASEB J, February 1, 2009; 23(2): 483 - 491.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
M. Olivier, D. J. Gregory, and G. Forget
Subversion Mechanisms by Which Leishmania Parasites Can Escape the Host Immune Response: a Signaling Point of View
Clin. Microbiol. Rev., April 1, 2005; 18(2): 293 - 305.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Kedzierski, J. Montgomery, D. Bullen, J. Curtis, E. Gardiner, A. Jimenez-Ruiz, and E. Handman
A Leucine-Rich Repeat Motif of Leishmania Parasite Surface Antigen 2 Binds to Macrophages through the Complement Receptor 3
J. Immunol., April 15, 2004; 172(8): 4902 - 4906.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
E. S. Van Amersfoort, T. J. C. Van Berkel, and J. Kuiper
Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock
Clin. Microbiol. Rev., July 1, 2003; 16(3): 379 - 414.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. Suzuki, A. K. Tanaka, M. S. Toledo, H. K. Takahashi, and A. H. Straus
Role of {beta}-D-Galactofuranose in Leishmania major Macrophage Invasion
Infect. Immun., December 1, 2002; 70(12): 6592 - 6596.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. Laufs, K. Muller, J. Fleischer, N. Reiling, N. Jahnke, J. C. Jensenius, W. Solbach, and T. Laskay
Intracellular Survival of Leishmania major in Neutrophil Granulocytes after Uptake in the Absence of Heat-Labile Serum Factors
Infect. Immun., February 1, 2002; 70(2): 826 - 835.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
R. Isberg and P Barnes
Subversion of integrins by enteropathogenic Yersinia
J. Cell Sci., January 1, 2001; 114(1): 21 - 28.
[Abstract] [PDF]


Home page
J. Immunol.Home page
M. Cuzzola, G. Mancuso, C. Beninati, C. Biondo, F. Genovese, F. Tomasello, T. H. Flo, T. Espevik, and G. Teti
{beta}2 Integrins Are Involved in Cytokine Responses to Whole Gram-Positive Bacteria
J. Immunol., June 1, 2000; 164(11): 5871 - 5876.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Troelstra, L. A. M. de Graaf-Miltenburg, T. van Bommel, J. Verhoef, K. P. M. Van Kessel, and J. A. G. Van Strijp
Lipopolysaccharide-Coated Erythrocytes Activate Human Neutrophils Via CD14 While Subsequent Binding Is Through CD11b/CD18
J. Immunol., April 1, 1999; 162(7): 4220 - 4225.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J Alexander, A. Satoskar, and D. Russell
Leishmania species: models of intracellular parasitism
J. Cell Sci., January 9, 1999; 112(18): 2993 - 3002.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
C Peters, T Aebischer, Y. Stierhof, M Fuchs, and P Overath
The role of macrophage receptors in adhesion and uptake of Leishmania mexicana amastigotes
J. Cell Sci., January 12, 1995; 108(12): 3715 - 3724.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.